Prostanoids as Regulators of Innate and Adaptive Immunity
Authors:
- Takako HirataTHTakako Hirata
- Shuh NarumiyaSNShuh Narumiya
- 1 January 2012
- book chapter
- Published by Elsevier
- Vol. 116, 143-174
Abstract
No abstract availableKeywords
Funding Information
- Astellas Pharma
- Ministry of Education, Culture, Sports, Science and Technology
This publication has 141 references indexed in Scilit:
- Prostaglandin E2–prostoglandin E receptor subtype 4 (EP4) signaling mediates UV irradiation-induced systemic immunosuppressionProceedings of the National Academy of Sciences, 2011
- Dual roles of PGE 2 -EP4 signaling in mouse experimental autoimmune encephalomyelitisProceedings of the National Academy of Sciences, 2010
- Arrestin Development: Emerging Roles for β-arrestins in Developmental Signaling PathwaysDevelopmental Cell, 2009
- The prostaglandin receptor EP2 activates multiple signaling pathways and -arrestin1 complex formation during mouse skin papilloma developmentCarcinogenesis, 2009
- Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility lociNature Genetics, 2009
- Prostaglandin E2 regulates Th17 cell differentiation and function through cyclic AMP and EP2/EP4 receptor signalingJournal of Experimental Medicine, 2009
- Prostaglandin E2 regulates B cell proliferation through a candidate tumor suppressor, Ptger4 Journal of Experimental Medicine, 2008
- Identification and pharmacological characterization of the prostaglandin FP receptor and FP receptor variant complexesBritish Journal of Pharmacology, 2008
- Facilitation of Th1-mediated immune response by prostaglandin E receptor EP1Journal of Experimental Medicine, 2007
- Activation of the D prostanoid 1 receptor suppresses asthma by modulation of lung dendritic cell function and induction of regulatory T cellsJournal of Experimental Medicine, 2007